Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cabrillo Advisors is a boutique financial advisory firm specializing in valuation and strategic services for the life sciences, healthcare, and technology industries. The firm provides a range of services including 409A valuations, financial reporting compliance under ASC 820, and transaction advisory for mergers and acquisitions. Cabrillo is well-regarded in the biotech ecosystem for its expertise in valuing complex securities and intellectual property for venture-backed startups. Its team often works closely with venture capital firms and emerging growth companies to navigate liquidity events and regulatory requirements. In January 2023, Cabrillo Advisors was acquired by MGO (Macias Gini & O'Connell LLP), integrating its specialized valuation practice into MGO's broader accounting and advisory platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cabrillo Advisors.